knowledge -WSS

knowledge

author：knowledge 2025-08-31 20:59:43 - browse：679

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Drinking less cuts risk of oral cavity, esophageal cancer: Report

WSS

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Elon Musk announces 'temporary limits' for reading Twitter posts

SEC charges former device maker CEO with $41 million fraud

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

explore

knowledge

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Prime Medicine, Myeloid Therapeutics clash over genome

Anesthesiologist group: stop taking Ozempic before surgery

Noem? Reynolds? A very early look at the Republican 'veepstakes'

At least 13 dead in Texas as scorching temps continue

Why health care costs have stayed mostly flat since 2010

Psychedelics group wrestles with new pharma identity

Carvykti CAR

Medicare proposal to cover medical devices draws a mixed reaction

HCA sued by state AG for quality issues at Mission Health

explore

Editas, Vertex strike deal on CRISPR

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Violet CEO on training clinicians to promote more inclusive care

Prime Medicine, Myeloid Therapeutics clash over genome

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Why health care costs have stayed mostly flat since 2010

explore

entertainment

knowledge

explore